RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
Excellence in Pediatrics
May 17, 2022
Excellence in Pediatrics
May 17, 2022
Respiratory Syncytial Virus Bronchiolitis Hospitalizations in Young Infants After the Introduction of Paid Family Leave in New York State, 2015‒2019
Excellence in Pediatrics
May 17, 2022
Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age Groups
Excellence in Pediatrics
May 17, 2022
Content validation of a caregiver diary to monitor severity and recovery of pediatric patients with respiratory syncytial virus infection
Excellence in Pediatrics
May 17, 2022
Change Over Time in Seasonality and Severity of Children Hospitalized With Respiratory Syncytial Virus Infection in Japan
Excellence in Pediatrics
May 12, 2022
Waning immunity against respiratory syncytial virus during the COVID-19 pandemic
Excellence in Pediatrics
May 11, 2022
Role and Diagnostic Performance of Host Epigenome in Respiratory Morbidity after RSV Infection: The EPIRESVi Study
Excellence in Pediatrics
May 11, 2022
The Health System Burden of RSV in Europe: EHMA’s White Paper
European Health Management Association (EHMA)
Apr 26, 2022
Burden of respiratory syncytial virus-associated lower respiratory infections in children in Spain from 2012 to 2018
Excellence in Pediatrics
Apr 05, 2022
Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus
Excellence in Pediatrics
Mar 31, 2022
SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses
Excellence in Pediatrics
Mar 31, 2022
The role of respiratory syncytial virus- and rhinovirus-induced bronchiolitis in recurrent wheeze and asthma-A systematic review and meta-analysis
Excellence in Pediatrics
Mar 31, 2022